(PUB) Publicis e - Overview
Stock: Advertising, Media, Digital, Health, Transformation
Dividends
| Dividend Yield | 3.90% |
| Yield on Cost 5y | 9.39% |
| Yield CAGR 5y | 15.83% |
| Payout Consistency | 97.6% |
| Payout Ratio | 53.3% |
| Risk 5d forecast | |
|---|---|
| Volatility | 45.0% |
| Relative Tail Risk | -4.23% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.91 |
| Alpha | -28.57 |
| Character TTM | |
|---|---|
| Beta | 0.177 |
| Beta Downside | 0.254 |
| Drawdowns 3y | |
|---|---|
| Max DD | 29.05% |
| CAGR/Max DD | 0.17 |
Description: PUB Publicis e December 19, 2025
Publicis Groupe S.A. (ticker PUB) is a French-based, globally diversified communications holding that delivers integrated marketing, media, digital transformation, and health-care communication services across North America, Europe, APAC, Latin America, Africa, and the Middle East. Its operating brands-Publicis Communications, Publicis Sapient, Publicis Media, and Publicis Health-are marketed under the “Power of One” premise, emphasizing cross-disciplinary collaboration for clients.
Key metrics (FY 2023): revenue of €13.0 billion, operating margin around 13 %, and a 10 % YoY increase in digital-ad spend, reflecting the broader industry shift toward programmatic and data-driven campaigns. The group’s exposure to the U.S. advertising market (≈55 % of revenue) makes it sensitive to macro-economic drivers such as consumer confidence and corporate capital-expenditure cycles.
Analysts should watch the pace of client budget reallocations from traditional to digital media, the execution of the ongoing cost-efficiency program, and any changes in the share-repurchase plan, as these factors directly affect earnings per share and cash-flow generation.
For a deeper, data-rich assessment of Publicis’s valuation dynamics, you may find ValueRay’s analytical platform worth exploring.
Piotroski VR‑10 (Strict, 0-10) 6.5
| Net Income: 2.74b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.12 > 0.02 and ΔFCF/TA 3.91 > 1.0 |
| NWC/Revenue: -2.94% < 20% (prev -8.88%; Δ 5.94% < -1%) |
| CFO/TA 0.13 > 3% & CFO 5.33b > Net Income 2.74b |
| Net Debt (3.45b) to EBITDA (5.17b): 0.67 < 3 |
| Current Ratio: 0.97 > 1.5 & < 3 |
| Outstanding Shares: last quarter (253.4m) vs 12m ago 0.04% < -2% |
| Gross Margin: 21.54% > 18% (prev 0.26%; Δ 2128 % > 0.5%) |
| Asset Turnover: 73.86% > 50% (prev 72.40%; Δ 1.46% > 0%) |
| Interest Coverage Ratio: 15.54 > 6 (EBITDA TTM 5.17b / Interest Expense TTM 254.5m) |
Altman Z'' 1.48
| A: -0.02 (Total Current Assets 23.07b - Total Current Liabilities 23.89b) / Total Assets 40.01b |
| B: 0.20 (Retained Earnings 8.08b / Total Assets 40.01b) |
| C: 0.10 (EBIT TTM 3.96b / Avg Total Assets 37.96b) |
| D: 0.24 (Book Value of Equity 7.16b / Total Liabilities 29.59b) |
| Altman-Z'' Score: 1.48 = BB |
Beneish M -2.78
| DSRI: 1.11 (Receivables 17.72b/14.74b, Revenue 28.04b/26.00b) |
| GMI: 1.23 (GM 21.54% / 26.41%) |
| AQI: 0.93 (AQ_t 0.37 / AQ_t-1 0.40) |
| SGI: 1.08 (Revenue 28.04b / 26.00b) |
| TATA: -0.06 (NI 2.74b - CFO 5.33b) / TA 40.01b) |
| Beneish M-Score: -2.78 (Cap -4..+1) = A |
What is the price of PUB shares?
Over the past week, the price has changed by -6.37%, over one month by -10.98%, over three months by -6.43% and over the past year by -23.90%.
Is PUB a buy, sell or hold?
What are the forecasts/targets for the PUB price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 113.3 | 43.7% |
| Analysts Target Price | - | - |
| ValueRay Target Price | 84.4 | 7.1% |
PUB Fundamental Data Overview February 07, 2026
P/E Trailing = 12.96
P/E Forward = 9.6432
P/S = 1.1723
P/B = 1.8414
P/EG = 2.2431
Revenue TTM = 28.04b EUR
EBIT TTM = 3.96b EUR
EBITDA TTM = 5.17b EUR
Long Term Debt = 3.08b EUR (from longTermDebt, last quarter)
Short Term Debt = 760.0m EUR (from shortTermDebt, last quarter)
Debt = 7.48b EUR (from shortLongTermDebtTotal, last quarter)
Net Debt = 3.45b EUR (from netDebt column, last quarter)
Enterprise Value = 25.22b EUR (21.94b + Debt 7.48b - CCE 4.20b)
Interest Coverage Ratio = 15.54 (Ebit TTM 3.96b / Interest Expense TTM 254.5m)
EV/FCF = 5.21x (Enterprise Value 25.22b / FCF TTM 4.84b)
FCF Yield = 19.18% (FCF TTM 4.84b / Enterprise Value 25.22b)
FCF Margin = 17.25% (FCF TTM 4.84b / Revenue TTM 28.04b)
Net Margin = 9.78% (Net Income TTM 2.74b / Revenue TTM 28.04b)
Gross Margin = 21.54% ((Revenue TTM 28.04b - Cost of Revenue TTM 22.00b) / Revenue TTM)
Gross Margin QoQ = 13.87% (prev 14.13%)
Tobins Q-Ratio = 0.63 (Enterprise Value 25.22b / Total Assets 40.01b)
Interest Expense / Debt = 0.17% (Interest Expense 13.0m / Debt 7.48b)
Taxrate = 27.28% (311.0m / 1.14b)
NOPAT = 2.88b (EBIT 3.96b * (1 - 27.28%))
Current Ratio = 0.97 (Total Current Assets 23.07b / Total Current Liabilities 23.89b)
Debt / Equity = 0.72 (Debt 7.48b / totalStockholderEquity, last quarter 10.45b)
Debt / EBITDA = 0.67 (Net Debt 3.45b / EBITDA 5.17b)
Debt / FCF = 0.71 (Net Debt 3.45b / FCF TTM 4.84b)
Total Stockholder Equity = 10.26b (last 4 quarters mean from totalStockholderEquity)
RoA = 7.22% (Net Income 2.74b / Total Assets 40.01b)
RoE = 26.71% (Net Income TTM 2.74b / Total Stockholder Equity 10.26b)
RoCE = 29.64% (EBIT 3.96b / Capital Employed (Equity 10.26b + L.T.Debt 3.08b))
RoIC = 21.30% (NOPAT 2.88b / Invested Capital 13.51b)
WACC = 4.93% (E(21.94b)/V(29.42b) * Re(6.57%) + D(7.48b)/V(29.42b) * Rd(0.17%) * (1-Tc(0.27)))
Discount Rate = 6.57% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: -33.33 | Cagr: -0.18%
[DCF Debug] Terminal Value 88.43% ; FCFF base≈4.08b ; Y1≈5.03b ; Y5≈8.57b
Fair Price DCF = 981.0 (EV 249.49b - Net Debt 3.45b = Equity 246.04b / Shares 250.8m; r=5.90% [WACC]; 5y FCF grow 25.0% → 2.90% )
EPS Correlation: 4.90 | EPS CAGR: -52.86% | SUE: -0.76 | # QB: 0
Revenue Correlation: 41.67 | Revenue CAGR: 39.99% | SUE: 0.94 | # QB: 2
EPS next Year (2026-12-31): EPS=7.95 | Chg30d=+0.034 | Revisions Net=+3 | Growth EPS=+5.5% | Growth Revenue=+4.2%